TCEP hydrochloride [51805-45-9]
Cat# NB-64-38935-1g
Size : 1g
Marca : Neo Biotech
TCEP hydrochloride (Synonyms: Tris(2-carboxyethyl)phosphine hydrochloride, TCEP HCl)
Catalog No. T7087 Copy Product Info
Purity: 99.93%
TCEP hydrochloride (Tris(2-carboxyethyl)phosphine hydrochloride) is a trialkylphosphine that selectively reduces proteolysis. TCEP hydrochloride is a non-thiol-reducing agent that promotes the binding of NF-κB-DNA.
TCEP hydrochloride
Copy Product InfoSynonyms Tris(2-carboxyethyl)phosphine hydrochloride, TCEP HCl
TCEP hydrochloride (Tris(2-carboxyethyl)phosphine hydrochloride) is a trialkylphosphine that selectively reduces proteolysis. TCEP hydrochloride is a non-thiol-reducing agent that promotes the binding of NF-κB-DNA.

Cas No. 51805-45-9

Customer service consultation
Select Batch
Purity:99.93%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
TCEP hydrochloride AI Summary
TCEP hydrochloride shows no significant inhibitory activity against HDAC1 and HDAC6 enzymes. Additionally, it does not exhibit significant growth inhibition (GI50 > 50000.0 nM) on human A549, MCF7, and WI38 cells after 96 hours, as determined by the sulphorhodamine B assay..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | TCEP hydrochloride (Tris(2-carboxyethyl)phosphine hydrochloride) is a trialkylphosphine that selectively reduces proteolysis. TCEP hydrochloride is a non-thiol-reducing agent that promotes the binding of NF-κB-DNA. |
| Targets&IC50 | MCF-7 cells:> 50 μM (GI50), WI-38 cells:> 50 μM (GI50), NS3/4A:12.8 μM, A549 cells:> 50 μM (GI50) |
| In vitro | METHODS: Human hepatocellular carcinoma cells HepG2 were treated with TCEP hydrochloride (100-400 µM) for 3 days, and cell viability was detected by MTT assay. RESULTS: The viability of HepG2 was significantly reduced to 25.68% and 70.92% after treatment with 200 and 400 µM TCEP for 3 days, whereas the lowest concentration of TCEP (100 µM) did not significantly reduce the viability of HepG2 (3.44%). [1] METHODS: Human peripheral blood mononuclear cell PBMCs were treated with TCEP hydrochloride (0.5-1 mM) for 24 h. Morphological and necrotic changes were assessed by Hoechst 33342/PI staining. RESULTS: Necrosis was observed in cells treated with 0.5 mM of TCEP. [2] |
| In vivo | METHODS: To investigate the neurotoxicity and its mechanism in mice, TCEP hydrochloride (10-100 mg/kg) was administered by gavage to Kunming mice once a day for 30 days. RESULTS: Compared with the control group, the high dose TCEP group showed a significant decrease in water intake and a significant increase in liver and spleen organ indices. In the water maze test, the escape latency of TCEP-exposed mice was longer than that of the control group, and the total swimming course of the high-dose TCEP group was higher than that of the control group, and the swimming time of the target quadrant was significantly shorter.TCEP exposure may cause neurotoxicity by increasing thyroid hormones and inducing oxidative damage in mice. [3] |
| Synonyms | Tris(2-carboxyethyl)phosphine hydrochloride, TCEP HCl |
| Molecular Weight | 286.65 |
| Formula | C9H16ClO6P |
| Cas No. | 51805-45-9 |
| Smiles | Cl.OC(=O)CCP(CCC(O)=O)CCC(O)=O |
| Relative Density. | 1.041 g/cm3 at 25℃ |
| Storage | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 252.5 mg/mL (880.87 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Saline: 2.75 mg/mL (9.59 mM), Solution. ![]() 5% DMSO+95% Saline: 1.45 mg/mL (5.06 mM), Solution. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Si può anche essere interessati nei seguenti prodotti:
Cat#
Descrizione
Cond.
Priced


